Herein, we demonstrate that CRP impairs the development of bone marrow (BM) cells into CD11c+ dendritic cells (DCs), professional antigen presenting cells that express ample FcγRIIB (7), are paramount for robust T cell responses (8), and are known to contribute to EAE/MS (9, 10, 11). Here, CRP is linked to myeloid sarcoma.